Commercial Excellence A privately held pharmaceutical company was preparing for the commercial launch of their first prescription drug. The Executive...
Compliance
Commercial Excellence
Global Pharmaceutical Manufacturer’s Reactive Response to a Corporate Integrity Agreement
While a global pharmaceutical company was under a Corporate Integrity Agreement (CIA), an associated brand was issued Risk...
Commercial Excellence
Combining Sales Coaching and Field Based Compliance Monitoring to Improve Results
A rapidly growing biotech company was interested in improving organizational efficiency and sales performance. As part of the...
Commercial Excellence
Field Based Monitoring: Best Practices for Pharma Companies
In the past five years, the Department of Justice (DOJ) has levied almost $22 billion in fines against...
Commercial Excellence
Compliant Communications Tips for Pharmaceutical Organizations
Given the heightened scrutiny that pharmaceutical companies face in today’s marketplace, all communication is discoverable and could lead...
Commercial Excellence
The New Compliance Landscape for Opioid Promotion
The opioid abuse epidemic in the United States has grown dramatically in recent years. The number of opioid prescriptions...
Commercial Excellence
Leveraging Reporting to Enhance Field Based Monitoring
The primary responsibility of pharmaceutical compliance professionals is to ensure their organizations adhere to government requirements and all...
Strategic Change
Mitigating Compliance Risks Across the Sales Execution Cycle
Companies need to identify and mitigate risks across the full range of sales’ job functions, not just when...